![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
PERIPHERAL ARTERIAL DISEASES
Italian Journal of Vascular and Endovascular Surgery 2014 December;21(4):201-4
Copyright © 2014 EDIZIONI MINERVA MEDICA
language: English
Directional atherectomy and adjunctive drug-coated balloon angioplasty
Sixt S. 1, Zeller T. 2
1 Angiologikum, Center for Interventional Angiology, Medical Care Prof. Mathey/Prof. Schofer, Hamburg, Germany; 2 University Heart Center, Freiburg Bad Krozingen, Bad Krozingen, Germany
The safety and efficiency of directed atherectomy (DA) have consistently been demonstrated in multiple clinical trails. The mechanical excision of the intima, however, seems to induce a reasonable inflammatory response which limit the long term clinical benefit. To control this inflammatory process it has been proposed to apply antiproliferative drugs, via a paclitaxel coated balloon (DCB). The combination of DA and consecutively DCB has the potential to provide optimal vessel preparation and to improve drug uptake during balloon angioplasty.